Literature DB >> 10630438

Detection of interferon regulatory factor-1 in lamina propria mononuclear cells in Crohn's disease.

M Clavell1, H Correa-Gracian, Z Liu, R Craver, R Brown, E Schmidt-Sommerfeld, J Udall, A Delgado, E Mannick.   

Abstract

BACKGROUND: The transcription factor, interferon regulatory factor (IRF)-1, is stimulated by interferon-gamma and regulates the expression of several genes implicated in the pathogenesis of inflammatory bowel disease, including interleukin-6, major histocompatibility complex class II molecules, and inducible nitric oxide synthase. Interferon regulatory factor-1 also stimulates naive CD4+ T-cells to differentiate into T-helper-1 cells, the T-cell subset that appears to be upregulated in Crohn's disease. The purpose of this study was to examine the expression of IRF-1 in the nuclei of lamina propria mononuclear cells in situ in colonoscopic biopsy specimens from pediatric patients with Crohn's disease, in patients with ulcerative colitis, and in control patients with no histopathologic abnormalities.
METHODS: Archival paraffin-embedded tissue sections were obtained from 25 pediatric patients with Crohn's disease, 6 patients with ulcerative colitis, and 12 control patients who had undergone colonoscopy. Tissue sections were stained with polyclonal rabbit anti-human antisera to IRF-1 and horseradish-peroxidase-conjugated, biotinylated, goat anti-rabbit secondary antibody. Slides were scored and scores compared among patient groups using analysis of variance.
RESULTS: Patients with Crohn's disease had significantly higher IRF-1 scores (95% confidence interval [CI], 1.70-2.04) than patients with ulcerative colitis (95% CI, 0.92-1.23) or control subjects (95% CI, 1.11-1.52).
CONCLUSIONS: Increased expression of IRF-1 in lamina propria mononuclear cells from patients with Crohn's disease may be relevant to the pathogenesis of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10630438     DOI: 10.1097/00005176-200001000-00016

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Authors:  Jian Wang; Xi Wang; Hong Yang; Dong Wu; Li Wang; Jiaming Qian
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  Crohn's disease and genetic hitchhiking at IBD5.

Authors:  Chad D Huff; David J Witherspoon; Yuhua Zhang; Chandler Gatenbee; Lee A Denson; Subra Kugathasan; Hakon Hakonarson; April Whiting; Chadwick T Davis; Wilfred Wu; Jinchuan Xing; W Scott Watkins; Michael J Bamshad; Jonathan P Bradfield; Kazima Bulayeva; Tatum S Simonson; Lynn B Jorde; Stephen L Guthery
Journal:  Mol Biol Evol       Date:  2011-08-04       Impact factor: 16.240

Review 3.  Transcriptional regulation of the intestinal luminal Na⁺ and Cl⁻ transporters.

Authors:  Jaleh Malakooti; Seema Saksena; Ravinder K Gill; Pradeep K Dudeja
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

Review 4.  Interferon regulatory factor signaling in autoimmune disease.

Authors:  Bharati Matta; Su Song; Dan Li; Betsy J Barnes
Journal:  Cytokine       Date:  2017-03-07       Impact factor: 3.861

5.  Application of Comparative Transcriptional Genomics to Identify Molecular Targets for Pediatric IBD.

Authors:  Kai Fang; Matthew B Grisham; Christopher G Kevil
Journal:  Front Immunol       Date:  2015-04-08       Impact factor: 7.561

6.  Interferon regulatory factor 1 (IRF-1) promotes intestinal group 3 innate lymphoid responses during Citrobacter rodentium infection.

Authors:  Angelika Schmalzl; Tamara Leupold; Lucas Kreiss; Maximilian Waldner; Sebastian Schürmann; Markus F Neurath; Christoph Becker; Stefan Wirtz
Journal:  Nat Commun       Date:  2022-09-29       Impact factor: 17.694

7.  Inactivation of Interferon Regulatory Factor 1 Causes Susceptibility to Colitis-Associated Colorectal Cancer.

Authors:  Thiviya Jeyakumar; Nassima Fodil; Lauren Van Der Kraak; Charles Meunier; Romain Cayrol; Kevin McGregor; David Langlais; Celia M T Greenwood; Nicole Beauchemin; Philippe Gros
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.